IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the Officials of the Company would be participating in the Investor Conference- 'Build India, New India 2022' being organized by Antique Stock Broking Ltd IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication of Postal ballot notice IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Postal Ballot Notice - Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Earnings Call for Q3FY22 of IOL Chemicals and Pharmaceuticals
Conference Call with IOL Chemicals and Pharmaceuticals Management and Analysts on Q3FY22 Performance and Outlook. Listen to the full earnings transcript. IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation Q3FY22 Q3FY22 Quarterly Result Announced for IOL Chemicals and Pharmaceuticals Ltd.
IOL Chemicals and Pharmaceuticals declares Q3FY22 result: IOL Chemicals and Pharmaceuticals Limited a leading manufacturer of Pharmaceutical (APIs) and Specialty Chemicals today posted its audited financial results for the quarter and nine months ending 31 st December 2021. The Company on QoQ basis recorded 3% growth in total income, the EBITDA has been increased by about 26% on QoQ basis. Dr Sanjay Chaturvedi, Chief Executive Officer said “the continuous volatility in the Chemicals pricing and lower volume of API products has impacted our margins on YoY basis while Q3 results show significant improvement from Q2. During Q3, the Company filed 4 DMFs with USFDA and 6 products have got GMP certificate from MOH Russia. Additionally, the company got approval from KFDA (Korean FDA) for 2 products. All these regulatory approvals will enable the Company for increased market penetration and add value to the business. With shaping up of improved operational efficiencies, cost cutting measures and investment in human capital, we are confident that the Company is on the way to sustainable growth.” Result PDF IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of newspaper publication of audited financial results for the quarter and nine months period ended 31st December 2021 IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Fixes Record Date for Interim Dividend
IOL Chemicals & Pharmaceuticals Ltd has informed BSE that the Company has fixed February 16, 2022 as the Record Date for the purpose of Payment of Interim Dividend.The payment of the Interim Dividend shall be made to the eligible shareholders before March 05, 2022. IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press release audited financial results for the quarter and nine months ending 31st December 2021 IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Corporate Action-Board approves Dividend
Pursuant to Regulations 30 & 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors in its meeting held on today i.e. 4th February 2022 has inter alia considered and approved the following: Declared an Interim Dividend of Rs. 4/- (Rupees Four Only) per Equity Share of Face Value Rs.10/- each for the Financial Year 2021-222. Fixed 16th February 2022 (Wednesday) as the Record Date to determine the names of the equity shareholders, who shall be entitled to receive the above said Interim Dividend. The payment of the Interim Dividend shall be made to the eligible shareholders before 5th March 2022.